Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

20.70
Delayed Data
As of Sep 29
 -0.88 / -4.08%
Today’s Change
19.10
Today|||52-Week Range
46.24
-52.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line147.1M176.2M80.2M125.3M
 
 
 
 
 
Depreciation8.9M13.8M25.0M26.7M
 
 
 
 
 
Total Other Cash Flow51.4M52.0M76.4M61.6M
 
 
 
 
 
Funds From Operations214.9M250.2M181.2M231.7M
 
 
 
 
 
Funds From/For Other Operating Expenses41.0M60.0M40.7M65.4M
 
 
 
 
 
Net Cash Flow - Operating Activities173.9M190.2M140.5M166.3M
 
 
 
 
 
 
InvestingIncrease In Investments-448.8M-385.3M-100.8M-164.5M
 
 
 
 
 
Decrease In Investments384.6M381.9M165.6M115.1M
 
 
 
 
 
Capital Expenditures-11.4M-14.3M-23.9M-5.0M
 
 
 
 
 
Net Assets From Acquisitions 0.000.000.00-37.0M
 
 
Net Cash Flow Investing-75.6M-17.7M40.9M-91.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale57.8M64.8M30.0M94.3M
 
 
 
 
 
Common Preferred Redeemed-146.3M-287.7M-210.7M-162.6M
 
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing7.9M0.003.4M0.00
 
 
 
Other Uses - Financing0.00-11.1M0.000.00
 
 
Net Cash Flow - Financing-80.6M-211.8M-177.3M-68.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00-4.8M-2.2M
 
 
 
 
Net Change In Cash17.7M-39.3M4.1M6.6M